Related Experiment Video
Updated: Jun 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Interleukin-10: a key cytokine in depression?
Susana Roque1, Margarida Correia-Neves, Ana Raquel Mesquita
1Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal.
Interleukin-10 (IL-10), an anti-inflammatory cytokine, may link depression symptoms like HPA axis disruption and cytokine imbalance. This finding suggests IL-10 as a potential new target for depression treatment.
Area of Science:
- Neuroimmunology
- Psychiatry
- Endocrinology
Background:
- Proinflammatory cytokines are increasingly linked to depression.
- Recent research indicates anti-inflammatory cytokines, like IL-10, also influence depressive behavior.
Purpose of the Study:
- To propose Interleukin-10 (IL-10) as a potential link between HPA axis disruption and cytokine imbalance in depression.
- To explore IL-10 as a novel therapeutic target for antidepressant therapy.
Main Methods:
- Literature review and theoretical synthesis of existing research on cytokines and depression.
- Analysis of the role of IL-10 in modulating depressive-like behaviors and HPA axis function.
Main Results:
- IL-10's anti-inflammatory properties suggest a role in regulating cytokine production.
- IL-10 may mediate the connection between HPA axis dysregulation and immune system imbalance in depression.
Conclusions:
- IL-10 is proposed as a key mediator in the pathophysiology of depression.
- Targeting IL-10 could offer a novel therapeutic strategy for treating depression and related disorders.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
G-protein Coupled Receptors
Antidepressant Drugs: MAOIs and Other Agents
